|
|
Article: GRAZAX(R) Demonstrates Significant Reductions on Asthma Symptoms in Children.
- Article from:
- PR Newswire Europe
- Article date:
- June 7, 2008
CopyrightCOPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BARCELONA, June 7 /PRNewswire/ --
- In Addition to Effects on Allergic Rhinitis (Hayfever), GRAZAX(R) Demonstrated Significant Reductions in Asthma Symptoms in Children Aged 5 to 16 Years Old
ALK-AbellA[sup.3] today presented successful results from a new clinical trial, GT-12, designed to measure the impact of GRAZAX(R) on allergic rhinitis and allergic asthma. GT-12 compared the effects of GRAZAX(R) with symptomatic medication versus symptomatic medication alone on the ability to reduce symptoms of allergic rhinitis and seasonal asthma.
A significant reduction of asthma symptoms was demonstrated. GRAZAX(R) reduced the combined asthma symptom ...